AbbVie Announces New CEO Robert A. Michael to Succeed Richard A. Gonzalez

On July 1, 2024, the global pharmaceutical company AbbVie (NYSE: ABBV) officially announced that Mr. Robert A. Michael will take on the role of Chief Executive Officer (CEO) effective immediately and will also join the company's Board of Directors. Previously, according to the company's announcement, Mr. Richard A. Gonzalez, who has served as CEO since the company's founding in 2013, will transition to the role of Executive Chairman of the AbbVie Board, continuing to contribute his wisdom and strength to the company.

Mr. Michael has deep industry experience, having previously served as President and Chief Operating Officer of AbbVie, and as a long-standing core member of the company's executive leadership team. During his tenure as President and COO, he was responsible for the company's global commercial operations, financial management, corporate human resources, global operations strategy, business development, and strategic planning. In 2018, he was promoted to Chief Financial Officer, and in the following years, he was appointed as Vice Chairman of Finance and Business Operations in 2021 and Vice Chairman and President in 2022. Over his 31-year career, Mr. Michael has demonstrated exceptional leadership across multiple business areas, including pharmaceuticals, aesthetics, diagnostics, diabetes care, and nutrition, starting his career as a finance development program member at Abbott.

The new AbbVie CEO, Mr. Robert A. Michael, stated: "I am honored to take on the role of AbbVie's CEO, and I look forward to building on the brilliant achievements of Richard Gonzalez. Providing innovative medicines for patients has always been our core mission, and the opportunities we face now are truly exciting. I look forward to working alongside our nearly 50,000 talented AbbVie employees to open a new chapter of growth for the company. I will also strive to preserve our company's culture, creating an even deeper impact for patients, employees, shareholders, and communities. I am grateful for the exceptional leadership and continued contribution of Richard Gonzalez over the past 11 years, and I look forward to him serving as Executive Chairman, providing his wisdom and guidance."

Regarding the leadership transition, outgoing AbbVie CEO Richard A. Gonzalez said, "I have full confidence in Rob. His experience, capabilities, and vision make him the ideal choice to lead AbbVie into the future. We have an outstanding leadership team and a solid strategic and financial foundation, which will ensure AbbVie is well-positioned for an even brighter future. As AbbVie's CEO, I have been privileged to work alongside many talented employees, and now I look forward to closely collaborating with Rob and the Board to continue fulfilling our commitment to patients worldwide."